Search - tctmd.com

Displaying 401 - 420 of 450

Sort: Relevancy | Date

Presentation ACC 2013

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Presenter: David R. Holmes, Jr.

March 08, 2013

News Conference News ACC 2013

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

Yael L. Maxwell

March 08, 2013

News Daily News

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

Jason Kahn

February 28, 2013

News Daily News

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

Jason Kahn

February 28, 2013

News Daily News

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

Caitlin E. Cox

January 30, 2013

News Daily News

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Caitlin E. Cox

January 30, 2013

Presentation

Percutaneous Left Atrial Appendage (LAA) Closure for Stroke Prophylaxis in A-fib Patients

Presenter: Vivek Y. Reddy

January 29, 2013

News Daily News

Un Dispositivo de Atrapamiento para el Cierre del AAI resulta Seguro y Eficaz en un Pequeño Estudio sobre Fibrilación Auricular

L.A. McKeown

January 16, 2013

News Daily News

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

L.A. McKeown

January 16, 2013

Presentation

Initial Experience with a Novel Percutaneous LAA Exclusion Device in Pts with A-fib, Increased Stroke Risk, and Contraindications to Anticoagulation

Presenter: A. Massumi

January 14, 2013

Presentation TCT 2012

Promising LAA Closure Devices and the Structural Heart Team Approach

Presenter: Carlos Pedra

October 25, 2012

Presentation TCT 2012

Tough Call During an LAA Occlusion

Presenter: Vivek Reddy

October 24, 2012

Presentation TCT 2012

Next-Generation LAA Occlusion Devices: AMPLATZER (St. Jude Medical) and WAVECREST (Coherex Medical)

Presenter: Horst Sievert

October 24, 2012

Presentation TCT 2012

Transcatheter LAA Occlusion: The Watchman Experience as Proof of Principle

Presenter: David Muller

October 24, 2012

Presentation TCT 2012

The SentreHeart Transpericardial Approach to LAA Occlusion

Presenter: Steven Yakubov

October 24, 2012

Presentation TCT 2012

Surgical LAA Exclusion: Is It Effective?

Presenter: A. Marc Gillinov

October 24, 2012

Presentation TCT 2012

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

Presenter: Peter Block

October 23, 2012

Presentation TCT 2012

Synthesis of the New ESC LAA Closure Guidelines

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

Quality-of-Life and Cost-Effectiveness After LAA Closure

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

Lifetech LAA Closure Device: Description and Preclinical Results

Presenter: Yat-Yin Lam

October 23, 2012

Advertisement

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Percutaneous Left Atrial Appendage (LAA) Closure for Stroke Prophylaxis in A-fib Patients

Un Dispositivo de Atrapamiento para el Cierre del AAI resulta Seguro y Eficaz en un Pequeño Estudio sobre Fibrilación Auricular

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

Initial Experience with a Novel Percutaneous LAA Exclusion Device in Pts with A-fib, Increased Stroke Risk, and Contraindications to Anticoagulation

Promising LAA Closure Devices and the Structural Heart Team Approach

Tough Call During an LAA Occlusion

Next-Generation LAA Occlusion Devices: AMPLATZER (St. Jude Medical) and WAVECREST (Coherex Medical)

Transcatheter LAA Occlusion: The Watchman Experience as Proof of Principle

The SentreHeart Transpericardial Approach to LAA Occlusion

Surgical LAA Exclusion: Is It Effective?

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

Synthesis of the New ESC LAA Closure Guidelines

Quality-of-Life and Cost-Effectiveness After LAA Closure

Lifetech LAA Closure Device: Description and Preclinical Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content